<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The purpose of the present study was to review the different clinical manifestations of primary gastrointestinal (GI) <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and <z:e sem="disease" ids="C0086692" disease_type="Neoplastic Process" abbrv="">benign tumors</z:e> in pediatric patients </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The demographic data, duration to diagnosis, clinical features, laboratory data, location and pathology of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>, and outcomes of pediatric patients from January 1984 to December 2009 were retrospectively reviewed </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: A total of 24 GI <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and 62 benign <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were diagnosed </plain></SENT>
<SENT sid="3" pm="."><plain>Patients in the benign group were mostly diagnosed in the first decade of life (73%), whereas majority of patients with <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> were older than 10 years (79%) </plain></SENT>
<SENT sid="4" pm="."><plain>The most <z:e sem="disease" ids="C1333132" disease_type="Neoplastic Process" abbrv="">common tumor</z:e> location in the benign group was the colorectum, whereas in the malignant group, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> were distributed equally in the small intestine and colorectum </plain></SENT>
<SENT sid="5" pm="."><plain>The median duration from <z:hpo ids='HP_0003674'>onset</z:hpo> to diagnosis in the benign group was longer than that of the malignant group (P&gt;00.05) </plain></SENT>
<SENT sid="6" pm="."><plain>There was statistically significant increase in the presence of <z:hpo ids='HP_0002573'>hematochezia</z:hpo> in patients with <z:e sem="disease" ids="C0086692" disease_type="Neoplastic Process" abbrv="">benign tumor</z:e> compared with those with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> (P&lt;00.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Among the <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e>, 79% presented with <z:hpo ids='HP_0002027'>abdominal pain</z:hpo>, followed by <z:hpo ids='HP_0001824'>weight loss</z:hpo> (25%), <z:hpo ids='HP_0002039'>anorexia</z:hpo> (25%), palpable mass (25%), and <z:hpo ids='HP_0001945'>fever</z:hpo> (21%), with statistically significant differences compared with the benign group (P&lt;00.05) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0001903'>Anemia</z:hpo> was found in 47% to 63% of patients in both groups (P&gt;00.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Two patients with <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> subsequently developed <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">malignancy</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: Different manifestations of GI <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> and <z:e sem="disease" ids="C0086692" disease_type="Neoplastic Process" abbrv="">benign tumors</z:e> may help pediatricians to detect these early </plain></SENT>
<SENT sid="11" pm="."><plain>Patients with <z:e sem="disease" ids="C0334108" disease_type="Neoplastic Process" abbrv="">polyposis</z:e> should be aware of the risk of malignant change </plain></SENT>
</text></document>